07:00 , Apr 19, 1999 |  BC Week In Review  |  Company News

CarboMed other research news

CarboMed researchers reported the cloning of CM201, a seven transmembrane domain receptor that binds the company's CM101 multi-repeat polysaccharide angiogenesis inhibitor. Data were presented at the American Association for Cancer Research meeting in Philadelphia. CM101...